Jennifer Litton

18PUBLICATIONS
106CO-AUTHORS
Predictive and prognostic markersCancer diagnosisMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (18)

|Dec 18, 2025
Imaging- and Tumor Biomarker-Based Multivariable Model for Early Prediction of Pathologic Complete Response to Neoadjuvant Systemic Therapy in Triple-Negative Breast Cancer.

Beatriz E Adrada, Mary S Guirguis, Lei Huo

|May 28, 2025
Implications of omitting sentinel lymph node biopsy on adjuvant decision making for patients with small breast cancers.

|Apr 22, 2025
Multicancer Early Detection Tests at a Crossroads: Commercial Availability Ahead of Definitive Evidence.

Carmen E Guerra, Jennifer Keating Litton, Carolina E Viswanath

|Jan 10, 2025
A pan-tumor review of the role of poly(adenosine diphosphate ribose) polymerase inhibitors.

Chadi Hage Chehade, Georges Gebrael, Nicolas Sayegh

|Oct 29, 2024
Outcomes of patients treated with chemotherapy for breast cancer during pregnancy compared with nonpregnant breast cancer patients treated with systemic therapy.

Helen M Johnson, Juhee Song, Carla L Warneke

|Oct 02, 2024
Targeting the Epidermal Growth Factor Receptor Pathway in Chemotherapy-Resistant Triple-Negative Breast Cancer: A Phase II Study.

Clinton Yam, Miral Patel, Holly A Hill

Pageof 3

Frequent Collaborators

5 joint publications

Debu Tripathy

5 joint publications

Jason White

4 joint publications

Rosalind P Candelaria

4 joint publications

Gaiane M Rauch